𝔖 Bobbio Scriptorium

✦ LIBER ✦

Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation

✍ Scribed by Stiff, P J; Miller, L A; Mumby, P; Kiley, K; Batiste, R; Porter, N; Potocki, K; Volle, M; Lichtenstein, S; Wojtowicz, S

Book ID: 110014896
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 120 KB
Volume: 37
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705264

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatic Veno-Occlusive Disease after Hem

Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Novel Insights to Pathogenesis, Current Status of Treatment, and Future Directions

✍ Richardson, P.G.; Ho, V.T.; Cutler, C.; Glotzbecker, B.; Antin, J.H.; Soiffer, R 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 114 KB

HLA Disparity and Rapid Immune Reconstit

HLA Disparity and Rapid Immune Reconstitution Do Not Overcome Propensity to Relapse in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant (HSCT) With Persistent Disease at the Time of Transplant

✍ D. Grosso; O. Alpdogan; M. Carabasi; B. Colombe; P. Cornett Farley; J. Filicko-O 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Low incidence of hepatic veno-occlusive

Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution

✍ Sonali Lakshminarayanan; Indira Sahdev; Meena Goyal; Adrianna Vlachos; Mark Atla 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT

✍ A. Shimoni; N. Shem-Tov; A. Rand; Y. Volchek; R. Yerushalmi; I. Hardan; A. Nagle 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Autologous stem cell transplantation in

Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients

✍ Terpos, E; Apperley, J F; Samson, D; Giles, C; Crawley, C; Kanfer, E; Olavarria, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 177 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB